Cannabis-Based Dronabinol Could Transform Alzheimer's Care, New Study Finds

A study reveals that dronabinol, a synthetic THC, decreases agitation in Alzheimer’s patients by 30%, according to recent findings. A recent study has found that dronabinol, a synthetic version of THC (the primary psychoactive component in cannabis), effectively reduces agitation in Alzheimer’s